The Multiple OutcoMe EvaluatioN of radiation Therapy Using the MR-linac Study

Summary

Radiation therapy is essential for cancer treatment, but it can cause serious side effects. MR-guided radiation therapy (MRGRT) offers more precise treatment by using real-time MRI, which may improve cure rates and reduce side effects. The MOMENTUM study aims to speed up the development of MRGRT and introduce the MR-Linac machine, which combines a linear accelerator with MRI, into clinical practice. The study will collect data from cancer patients receiving MR-Linac treatment to improve software, evaluate outcomes, and develop new treatment features. Participants will give consent for their MRI scans and may provide additional research imaging and patient-reported outcomes during treatment. No risks are expected for participants, and privacy will be protected by strict data security procedures.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 120

Accepts healthy participants: Yes

Inclusion criteria:

- Patients 18 years or older with a diagnosis of cancer, regardless of clinical site or stage
- Planned to receive a course of MR-guided adaptive radiotherapy using the MR-LINAC
- Ability to provide informed consent

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Sangjune Laurence Lee, MD, FRCPC Division of Radiation Oncology, University of Calgary, Arthur J.E. Child Comprehensive Cancer Centre (CCC) 3395 Hospital Dr NW, Calgary, AB T2N 4N1 Ph: 403-521-3164, Fax: 403-283-1651

Principal investigator:

Sangjune Lee

Clinical trial:

No

REB-ID:

HREBA.CC-24-0312